Amryt Pharma Plc - ADR logo

Amryt Pharma Plc - ADR Share Price (NASDAQ: AMYT)

▲

-14.7

(-100%)

Last updated on

Bell Icon

This instrument is not available for trading on the INDmoney app on 11 Apr 2023

Check the interactive Amryt Pharma Plc - ADR Stock chart to analyse performance

Amryt Pharma Plc - ADR Key Stats

Check Amryt Pharma Plc - ADR key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$14.7
Open
$14.71
Market Capitalization
$943.4M
Today's Volume
$2.4M
Revenue TTM
$243.6M
EBITDA
$-73.8M
Earnings Per Share (EPS)
$0.37
PE Ratio
39.7
Dividend Yield
0.0%
Profit Margin
-0.32%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-0.25%

Global Institutional Holdings in Amryt Pharma Plc - ADR

  • Name

    Holdings %

  • Athyrium Capital Management LP

    13.81%

  • Highbridge Capital Management, LLC

    9.88%

  • Stonepine Capital Management Llc

    9.88%

  • Rubric Capital Management LP

    5.61%

  • Mpm Asset Management, LLC

    4.16%

  • EdgePoint Investment Group, Inc.

    3.55%

Analyst Recommendation on Amryt Pharma Plc - ADR Stock

Rating
Trend

Buy

    100%Buy

    0%Hold

    0%Sell

Based on 5 Wall street analysts offering stock ratings for Amryt Pharma Plc - ADR(by analysts ranked 0 to 5 stars)

About Amryt Pharma Plc - ADR

Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy; oral octreotide, a long-term maintenance therapy in acromegaly patients; and lomitapide, an adjunct to a low-fat diet and other lipid-lowering medicinal products for adults with the Homozygous familial Hypercholesteraemia. Its development candidates include Oleogel-S10 for the cutaneous manifestations of Junctional and Dystrophic Epidermolysis Bullosa (EB), a rare and distressing genetic skin disorder affecting young children and adults; and AP103, a pre-clinical gene therapy for patients with dystrophic EB. The company sells its products in the Americas, Europe, and the Middle East. Amryt Pharma plc was founded in 2015 and is headquartered in Dublin, Ireland.
Organization
Amryt Pharma Plc - ADR
Employees
289
CEO
Dr. Joseph A. Wiley
Industry
Health Technology

Important FAQs about investing in AMYT Stock from India :

What is Amryt Pharma Plc - ADR share price today?

Amryt Pharma Plc - ADR share price today is as on at the close of the market. Amryt Pharma Plc - ADR share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Amryt Pharma Plc - ADR share?

Amryt Pharma Plc - ADR share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Amryt Pharma Plc - ADR stock price today i.e. is closed at , lower by 100% versus the 52 week high.

How to invest in Amryt Pharma Plc - ADR Stock (AMYT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Amryt Pharma Plc - ADR on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Amryt Pharma Plc - ADR Shares .

What is the minimum amount required to buy Amryt Pharma Plc - ADR Stock (AMYT) from India?

Indian investors can start investing in Amryt Pharma Plc - ADR (AMYT) shares with as little as ₹93.46 or $1 (as of March 21, 2026) using the INDmoney app.
For example: If you want to invest $10 or ₹934.60 in Amryt Pharma Plc - ADR stock (as per the Rupee-Dollar exchange rate as on March 21, 2026). Learn more about fractional shares .

What are the returns that Amryt Pharma Plc - ADR has given to Indian investors in the last 5 years?

Amryt Pharma Plc - ADR stock has given 0.0% share price returns and 29.12% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?